Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
Cited 23 time in
Cited 0 time in
- Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
- Hwang I; Seung Hong Choi; Kim YJ; Kim K.G.; Lee A.L.; Yun T.J.; Kim J.-h.; Sohn C.-H.
- AMERICAN JOURNAL OF NEURORADIOLOGY, v.34, no.12, pp.2343 - 2348
- AMER SOC NEURORADIOLOGY
- BACKGROUNDANDPURPOSE: High b-valueDWIhas been expected to have an additional diagnostic role and demonstrated some promising
results in head and neck cancer. The aim of this study was to evaluate the diagnostic performance of DWI at a high b-value (b2000 s/mm2)
compared with a standard b-value (b1000 s/mm2) and the ratio of ADC values of high and standard b-values for their ability to differentiate
between recurrent tumor and posttreatment changes after the treatment of head and neck squamous cell carcinoma.
MATERIALS AND METHODS: A total of 33 patients diagnosed with head and neck squamous cell carcinoma were enrolled in the present
study; all had contrast-enhancing lesions on follow-up MR imaging. All patients underwent single-shot echo-planar DWI at b1000 s/mm2
and b2000 s/mm2, and corresponding ADC maps were generated (ADC1000 and ADC2000, respectively). The mean ADC1000, ADC2000, and
ADCratio (ADCratio ADC2000/ADC1000 100) values were evaluated within a manually placed ROI with contrast-enhanced T1-weighted
images as references. For the statistical analysis, we performed a Student t test and multivariate logistic regression.
RESULTS: The mean ADC1000 in recurrent tumor was significantly lower than that in posttreatment changes (P.001), whereas the mean
ADC2000 resulted in no significant difference (P .365). The mean ADCratio was significantly higher in recurrent tumor than that in
posttreatment changes (73.5 7.2% vs 56.9 8.8%, respectively; P .001). Multivariate logistic regression analysis revealed that the
ADCratio was the only independently differentiating variable (P .024). The sensitivity, specificity, and accuracy of ADCratio were 95.0%,
69.2%, and 84.8%, respectively, by use of the optimal cutoff value of 62.6%.
CONCLUSIONS: We suggest that the ADCratio calculated from the ADC1000 and ADC2000 is a promising value for the differentiation of
recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma.
ABBREVIATIONS: ADC1000ADC value calculated at b0 and 1000 s/mm2; ADC2000ADC value calculated at b0 and 2000 s/mm2; ADCratioratio of ADC2000
over ADC1000; HNSCC head and neck squamous cell carcinoma
Appears in Collections:
- Center for Nanoparticle Research(나노입자 연구단) > Journal Papers (저널논문)
- Files in This Item:
Differentiation of recurrent tumor and posttreatment changes.pdfDownload
- Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.